Literature DB >> 879759

Penetration of cefamandole into spinal fluid.

E A Steinberg, G D Overturf, L J Baraff, J Wilkins.   

Abstract

Twelve patients, aged 6 months to 62 years, with proven bacterial meningitis, were given a single intravenous dose of cefamandole (33 mg/kg) 75 to 140 min before a routine lumbar puncture. Infecting organisms included Haemophilus influenzae (eight cases), Streptococcus pneumoniae (two cases), and Neisseria meningitidis and beta-hemolytic streptococcus (one each). Cerebrospinal fluid (CSF) was analyzed by microbiological assay for cefamandole. The median concentration was 0.60 mug/ml, ranging from undetectable to 7.4 mug/ml. CSF cefamandole concentrations correlated with CSF protein: in six patients with CSF protein less than 100 mug/dl, the range of drug concentration was 0 to 0.62 mug/ml; and in six patients with CSF protein above 100 mg/dl, the range was 0.57 to 7.4 mug/ml. No significant correlation was noted between severity of illness, type of organism involved, or patient age and concentration of drug achieved.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 879759      PMCID: PMC352105          DOI: 10.1128/AAC.11.6.933

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Susceptibility of pneumococci and Haemophilus influenzae to antibacterial agents.

Authors:  M Finland; C Garner; C Wilcox; L D Sabath
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

2.  The penetration of broad-spectrum antibiotics into the cerebrospinal fluid.

Authors:  L H Taber; M D Yow; F G Nieberg
Journal:  Ann N Y Acad Sci       Date:  1967-09-27       Impact factor: 5.691

3.  Penetration of cephalothin into the spinal fluid.

Authors:  N J Vianna; D Kaye
Journal:  Am J Med Sci       Date:  1967-08       Impact factor: 2.378

4.  Cephalothin and cephaloridine therapy for bacterial meningitis.

Authors:  L S Fisher; A W Chow; T T Yoshikawa; L B Guze
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

5.  Ampicillin in the treatment of acute suppurative meningitis.

Authors:  F F Barrett; W A Eardley; M D Yow; H A Leverett
Journal:  J Pediatr       Date:  1966-09       Impact factor: 4.406

6.  Cefamandole: in vitro and clinical pharmacokinetics.

Authors:  R S Griffith; H R Black; G L Brier; J D Wolny
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

7.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

8.  Comparative trial of carbenicillin and ampicillin therapy for purulent meningitis.

Authors:  G D Overturf; E A Steinberg; A E Underman; J Wilkins; J M Leedom; A W Mathies; P F Wehrle
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

9.  Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.

Authors:  S Eykyn; C Jenkins; A King; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

10.  Penicillins in the treatment of bacterial meningitis.

Authors:  A W Mathies
Journal:  J R Coll Physicians Lond       Date:  1972-01
View more
  5 in total

1.  Pharmacokinetics of cefamandole and ampicillin in experimental meningitis.

Authors:  H N Beaty; E Walters
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

2.  Comparative in vitro activity of five cephalosporins against Lactobacilli.

Authors:  A S Bayer; A W Chow; N F Concepcion; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

3.  Pharmacokinetics and safety of cefamandole in newborn infants.

Authors:  M M Agbayani; A J Khan; P Kemawikasit; W Rosenfeld; D Salazar; K Kumar; L Glass; H E Evans
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

4.  Cefoxitin concentrations in the cerebrospinal fluids of patients with meningitis.

Authors:  G Humbert; A Leroy; J P Rogez; C Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

5.  Moxalactam (LY127935) in treatment of meningitis due to gram-negative bacilli.

Authors:  J F Fisher; M J Carter; J Parsons; J P Rissing
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.